The Procter & Gamble Company (PG): Is It on the Road to Recovery?

Page 2 of 2

One concern, though, is how the company handled news of Venezuela’s currency devaluation. The Clorox Company (NYSE:CLX) and Colgate-Palmolive Company (NYSE:CL) also felt the pinch, with Clorox taking about a $0.05 to $0.10 per-share earnings hit and Colgate losing about $0.50 per share. But they also addressed the potential devaluation more proactively than P&G did. The Clorox Company (NYSE:CLX) actually anticipated the devaluation in its February earnings report, projecting the potential hit if a devaluation took place. Colgate didn’t provide specific guidance in advance but clearly saw it as an issue, delivering on a promise to give prompt guidance revisions after the devaluation occurred.

In The Procter & Gamble Company (NYSE:PG)’s earnings report, watch for how well the company is able to follow through on last quarter’s growth. If P&G’s old complacency starts slipping back into its results, then the stock could easily start lagging behind its peers once again.

The article Is Procter & Gamble on the Road to Recovery? originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Procter & Gamble and Unilever plc (ADR) (NYSE:UL).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Page 2 of 2